Target intelligence / Profile preview

Multiple downstream pathways and cell types via secreted cytokines, growth factors, and extracellular vesicles

Molecular classification
Other
01

Overview

The phrase 'Multiple downstream pathways and cell types via secreted cytokines, growth factors, and extracellular vesicles' refers to the complex paracrine and autocrine signaling networks used by cells to modulate their environment and communicate with distant tissues. This process is a fundamental mechanism in regenerative medicine and immunology, particularly regarding the therapeutic effects of Mesenchymal Stem Cells (MSCs), which exert their influence through a 'secretome' rather than direct cell-to-cell contact (Source: PubMed, PMC7034050). Cytokines and growth factors within this system bind to specific transmembrane receptors to activate intracellular cascades like the JAK/STAT or PI3K/Akt pathways, while extracellular vesicles (EVs) transport bioactive lipids, proteins, and RNAs directly into recipient cells (Source: Nature Reviews Molecular Cell Biology, 19:213–228). Because this description encompasses hundreds of distinct molecular entities and diverse biological processes, it does not represent a single, discrete therapeutic target. Instead, it characterizes a multi-faceted mode of action often targeted by complex biologics, cell-free therapies, or broad-spectrum immunomodulators. In clinical contexts, understanding these pathways is critical for managing systemic inflammation and promoting tissue repair in degenerative diseases.

Other names
Paracrine signalingCell secretomeIntercellular communicationExosome-mediated signalingHumoral signaling
02

Mechanism of action

This entry describes a broad physiological mechanism of action involving the coordinated release of various signaling molecules and vesicles rather than a single drug-target interaction.

03

Biological functions

Signal transductionCell-to-cell communicationImmune responseCell proliferationTissue repair
04

Disease associations

InflammationCancerNeurodegenerative diseaseCardiovascular diseaseAutoimmune disease
05

Safety considerations

Pleiotropic effects leading to off-target systemic toxicityPotential for cytokine release syndromeComplexity in characterizing and standardizing multi-component secretomesRisk of promoting tumor microenvironments in oncology
06

Biomarkers

Exosome surface markers (CD9, CD63, CD81)Circulating cytokine levelsGrowth factor expression profiles

Beyond the preview

Go deeper on Multiple downstream pathways and cell types via secreted cytokines, growth factors, and extracellular vesicles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple downstream pathways and cell types via secreted cytokines, growth factors, and extracellular vesicles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call